Targeting the Leading Cause of Death
Dr. Terry Dubrow, star of the hit TV show “Botched,” is speaking out in defense of the weight-loss drug Ozempic. According to Dubrow, this medication effectively targets the number one cause of death in the country – heart and cardiovascular disease, cancer, neurodegenerative disorders, and diabetes. He believes that if used safely and appropriately, Ozempic can be a game-changer in health and wellness.
Ending the Stigma
Dubrow is also urging people to stop shaming Ozempic and other weight-loss drugs. He emphasizes that these medications should be treated like any other prescription drug and used under a physician’s guidance. Dubrow hopes to create a community where individuals can openly discuss their experiences and learn how to use these drugs properly.
A Clash of Opinions
The controversy surrounding Ozempic escalated when fitness trainer Jillian Michaels voiced her concerns about its negative side effects. However, Dubrow dismisses Michaels’ comments, stating that he is not interested in debating scientific and medical issues with a personal trainer. He believes that influential figures like Michaels should not discourage people from exploring the potential benefits of these new weight-loss drugs.
Clarifying Misinterpretations
Dubrow clarifies that his previous statements about side effects from weight-loss drugs were taken out of context. He explains that he was advocating for an open dialogue about the proper use of these drugs and the potential risks involved. While some patients have experienced significant side effects, Dubrow emphasizes the importance of using these medications under medical supervision.
Personal Experience with Ozempic
Contrary to accusations of bias, Dubrow reveals that he recently tried a similar drug to Ozempic called Mounjaro. He wanted to understand its effects firsthand and found that it significantly suppressed his appetite. Although he experienced mild nausea initially, it subsided within a few days, and he noticed a remarkable change in his eating habits. Dubrow believes that these drugs, when used responsibly, can be effective tools for weight loss.
A Well-Studied Option
Dubrow reassures skeptics that weight-loss drugs like Ozempic have been extensively studied for over a decade. They have been deemed safe for use in diabetics and have recently been explored for non-diabetic weight loss. While they do come with potential side effects such as nausea and diarrhea, Dubrow compares these side effect profiles to those of common drugs like aspirin. He argues that given their FDA approval and long-standing research, these medications are worth considering alongside lifestyle changes.
A Medical Breakthrough
Dubrow believes that weight-loss drugs like Ozempic represent a significant medical breakthrough. He acknowledges that while diet and exercise are essential for weight loss, they are not always enough for everyone. These medications offer a powerful tool to combat the obesity epidemic plaguing the country. Dubrow finds the mechanism behind these drugs fascinating and their effectiveness remarkable.